Major surgery increases serum levels of vascular endothelial growth factor only temporarily

American Journal of Surgery

Volumn 179, Issue 1, 2000, Pages 57-59

  Bondestam, Jonas ^a   Salven, Petri ^a   Jääskelä Saari, Hilkka ^a   Ikonen, Tuija ^a   Lepäntalo, Mauri ^a   Mattila, Severi ^a   Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANEURYSM SURGERY; ANGIOGENESIS; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MALE; MINOR SURGERY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN ISOFORMS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033994651     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00253-6     Document Type: Article

References (10)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.
2. Senger D.R., Van de Water L., Brown L.F., et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:1993;303-324.
3. Dirix L.Y., Vermeulen P.B., Hubens G., et al. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol. 7:1996;843-848.
4. Salven P., Ruotsalainen T., Mattson K., Joensuu H. A high pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer. Int J Cancer. 79:1998;144-146.
5. Salven P., Teerenhovi L., Joensuu H. A high pretreatment serum VEGF concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood. 90:1997;3167-3172.
6. Tempfer C., Obermair A., Hefler L., et al. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol. 92:1998;360-366.
7. Banai S., Shweiki D., Pinson A., et al. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia implications for coronary angiogenesis . Cardiovasc Res. 28:1994;1176-1179.
8. Corral C.J., Siddiqui A., Liancun W., et al. Vascular endothelial growth factor is more important than basic fibroblast growth factor during ischemic wound healing. Arch Surg. 134:1999;200-205.
9. Freeman M.R., Schneck F.X., Gagnon M.L., et al. Peripheral T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor a potential role for T cells in angiogenesis . Cancer Res. 55:1995;4140-4145.
10. Salven P., Orpana A., Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res. 5:1999;487-491.